Sunrise

Enroll Now

Type of Study:

Type 1 diabetes patients who are 18 – 40 years

Title of Study:

Evaluate the Safety of TOL-3021 in Patients With New Onset or Established diagnosis of Type 1 diabetes within 5 years of screening.

Short Title:

TOL-3021

Study Length: 52 Weeks

Target Age/Sex: 18 – 40 years, Male and Female

Benefits:

Participants will receive at no cost: study product, study materials and study-specific procedures

Link: ClinicalTrials.gov